153 related articles for article (PubMed ID: 33041663)
1. Association between copy-number alteration of +20q, -14q and -18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma.
Wang L; Li Y; Lyu Y; Wen H; Feng C
Cancer Cell Int; 2020; 20():482. PubMed ID: 33041663
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of copy number variance and sensitivity to common targeted therapy in clear cell renal cell carcinoma: In silico analysis with in vitro validation.
Li Y; Shen Y; Zhu Z; Wen H; Feng C
Cancer Med; 2020 Aug; 9(16):6020-6029. PubMed ID: 32628820
[TBL] [Abstract][Full Text] [Related]
3. HIF1α is not a target of 14q deletion in clear cell renal cancer.
Shenoy N
Sci Rep; 2020 Oct; 10(1):17642. PubMed ID: 33077781
[TBL] [Abstract][Full Text] [Related]
4. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC).
Bielecka ZF; Czarnecka AM; Solarek W; Kornakiewicz A; Szczylik C
Curr Signal Transduct Ther; 2014 Dec; 8(3):218-228. PubMed ID: 25152704
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR-15b Promotes Resistance to Sunitinib in Renal Cell Carcinoma.
Lu L; Li Y; Wen H; Feng C
J Cancer; 2019; 10(15):3389-3396. PubMed ID: 31293642
[No Abstract] [Full Text] [Related]
7. Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines.
Martin B; Edeline J; Patard JJ; Oger E; Jouan F; Boulanger G; Zerrouki S; Vigneau C; Rioux-Leclercq N
J Cancer Res Clin Oncol; 2012 Jun; 138(6):907-16. PubMed ID: 22322364
[TBL] [Abstract][Full Text] [Related]
8. Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors.
Lai Y; Wu W; Liang X; Zhong F; An L; Chang Z; Cai C; He Z; Wu W
Transl Oncol; 2023 Sep; 35():101712. PubMed ID: 37354638
[TBL] [Abstract][Full Text] [Related]
9. Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification.
Yoshikawa Y; Yamada Y; Emi M; Atanesyan L; Smout J; de Groot K; Savola S; Nakanishi-Shinkai Y; Kanematsu A; Nojima M; Ohmuraya M; Hashimoto-Tamaoki T; Yamamoto S
Cancer Sci; 2022 Jan; 113(1):297-307. PubMed ID: 34687579
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of steroid sulfotransferase genes is associated with worsened prognosis and with immune exclusion in clear cell-renal cell carcinoma.
Li Y; Ding Q; Xiong Z; Wen H; Feng C
Aging (Albany NY); 2019 Oct; 11(20):9209-9219. PubMed ID: 31655797
[TBL] [Abstract][Full Text] [Related]
11. Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC).
Armesto M; Marquez M; Arestin M; Errarte P; Rubio A; Manterola L; López JI; Lawrie CH
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503211
[TBL] [Abstract][Full Text] [Related]
12. The study on copy number alteration of clear cell renal cancer in Chinese population.
Zhang N; Chen S; Jiang G; Wu Y; Shao J; Liu W; Wang X; Na R; Xu J
J Cancer; 2020; 11(1):16-24. PubMed ID: 31892969
[No Abstract] [Full Text] [Related]
13. Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma.
Peng Q; Wang L; Zhao D; Lv Y; Wang H; Chen G; Wang J; Xu W
J Cancer; 2019; 10(5):1237-1251. PubMed ID: 30854133
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma.
Fernández-Pello S; Hofmann F; Tahbaz R; Marconi L; Lam TB; Albiges L; Bensalah K; Canfield SE; Dabestani S; Giles RH; Hora M; Kuczyk MA; Merseburger AS; Powles T; Staehler M; Volpe A; Ljungberg B; Bex A
Eur Urol; 2017 Mar; 71(3):426-436. PubMed ID: 27939075
[TBL] [Abstract][Full Text] [Related]
15. The m6A-regulation and single cell effect pattern in sunitinib resistance on clear cell renal cell carcinoma: Identification and validation of targets.
Deng Y; Wang F; Wu X; Du K; Yang Q; Xia T
Front Pharmacol; 2023; 14():1131610. PubMed ID: 37063301
[No Abstract] [Full Text] [Related]
16. Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.
Loo LW; Tiirikainen M; Cheng I; Lum-Jones A; Seifried A; Church JM; Gryfe R; Weisenberger DJ; Lindor NM; Gallinger S; Haile RW; Duggan DJ; Thibodeau SN; Casey G; Le Marchand L
Genes Chromosomes Cancer; 2013 May; 52(5):450-66. PubMed ID: 23341073
[TBL] [Abstract][Full Text] [Related]
17. Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting.
Beuselinck B; Job S; Becht E; Karadimou A; Verkarre V; Couchy G; Giraldo N; Rioux-Leclercq N; Molinié V; Sibony M; Elaidi R; Teghom C; Patard JJ; Méjean A; Fridman WH; Sautès-Fridman C; de Reyniès A; Oudard S; Zucman-Rossi J
Clin Cancer Res; 2015 Mar; 21(6):1329-39. PubMed ID: 25583177
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic Properties of Axitinib versus Sorafenib Following Sunitinib Resistance in Human Endothelial Cells-A View towards Second Line Renal Cell Carcinoma Treatment.
Juengel E; Schnalke P; Rutz J; Maxeiner S; Chun FK; Blaheta RA
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829859
[TBL] [Abstract][Full Text] [Related]
19. Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC).
Zhong W; Zhang F; Huang C; Lin Y; Huang J
J Cancer; 2021; 12(11):3265-3276. PubMed ID: 33976736
[TBL] [Abstract][Full Text] [Related]
20. Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma.
Song Z; Li Z; Han W; Zhu C; Lou N; Li X; Luo G; Peng S; Li G; Zhao Y; Guo Y
Aging (Albany NY); 2020 Nov; 13(2):1842-1858. PubMed ID: 33201837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
